147 related articles for article (PubMed ID: 19377988)
1. Ligand-regulated peptide aptamers.
Miller RA
Methods Mol Biol; 2009; 535():315-31. PubMed ID: 19377988
[TBL] [Abstract][Full Text] [Related]
2. Isolation of Peptide aptamers to target protein function.
Lopez-Ochoa L; Nash TE; Ramirez-Prado J; Hanley-Bowdoin L
Methods Mol Biol; 2009; 535():333-60. PubMed ID: 19377987
[TBL] [Abstract][Full Text] [Related]
3. Selection and characterization of large collections of peptide aptamers through optimized yeast two-hybrid procedures.
Bickle MB; Dusserre E; Moncorgé O; Bottin H; Colas P
Nat Protoc; 2006; 1(3):1066-91. PubMed ID: 17406388
[TBL] [Abstract][Full Text] [Related]
4. Peptide aptamers as guides for small-molecule drug discovery.
Baines IC; Colas P
Drug Discov Today; 2006 Apr; 11(7-8):334-41. PubMed ID: 16580975
[TBL] [Abstract][Full Text] [Related]
5. Ligand-regulated peptide aptamers that inhibit the 5'-AMP-activated protein kinase.
Miller RA; Binkowski BF; Belshaw PJ
J Mol Biol; 2007 Jan; 365(4):945-57. PubMed ID: 17116308
[TBL] [Abstract][Full Text] [Related]
6. Peptide aptamers: development and applications.
Reverdatto S; Burz DS; Shekhtman A
Curr Top Med Chem; 2015; 15(12):1082-101. PubMed ID: 25866267
[TBL] [Abstract][Full Text] [Related]
7. Peptide aptamers for small molecule drug discovery.
Bardou C; Borie C; Bickle M; Rudkin BB; Colas P
Methods Mol Biol; 2009; 535():373-88. PubMed ID: 19377984
[TBL] [Abstract][Full Text] [Related]
8. Ligand-regulated peptides: a general approach for modulating protein-peptide interactions with small molecules.
Binkowski BF; Miller RA; Belshaw PJ
Chem Biol; 2005 Jul; 12(7):847-55. PubMed ID: 16039531
[TBL] [Abstract][Full Text] [Related]
9. Selection of peptides interfering with protein-protein interaction.
Gaida A; Hagemann UB; Mattay D; Räuber C; Müller KM; Arndt KM
Methods Mol Biol; 2009; 535():263-91. PubMed ID: 19377990
[TBL] [Abstract][Full Text] [Related]
10. In vitro selection of peptide aptamers with affinity to single-wall carbon nanotubes using a ribosome display.
Li Z; Uzawa T; Tanaka T; Hida A; Ishibashi K; Katakura H; Kobatake E; Ito Y
Biotechnol Lett; 2013 Jan; 35(1):39-45. PubMed ID: 22986537
[TBL] [Abstract][Full Text] [Related]
11. Aptamer selection based on inhibitory activity using an evolution-mimicking algorithm.
Noma T; Ikebukuro K
Biochem Biophys Res Commun; 2006 Aug; 347(1):226-31. PubMed ID: 16815302
[TBL] [Abstract][Full Text] [Related]
12. Combining SELEX and the yeast three-hybrid system for in vivo selection and classification of RNA aptamers.
König J; Julius C; Baumann S; Homann M; Göringer HU; Feldbrügge M
RNA; 2007 Apr; 13(4):614-22. PubMed ID: 17283213
[TBL] [Abstract][Full Text] [Related]
13. Evolution of disulfide-rich peptide aptamers using cDNA display.
Mochizuki Y; Nemoto N
Methods Mol Biol; 2012; 805():237-50. PubMed ID: 22094809
[TBL] [Abstract][Full Text] [Related]
14. Polypeptide aptamer selection using a stabilized ribosome display.
Wang W; Hara S; Liu M; Aigaki T; Shimizu S; Ito Y
J Biosci Bioeng; 2011 Nov; 112(5):515-7. PubMed ID: 21813322
[TBL] [Abstract][Full Text] [Related]
15. In vitro selection of protein-binding DNA aptamers as ligands for biosensing applications.
Navani NK; Mok WK; Yingfu L
Methods Mol Biol; 2009; 504():399-415. PubMed ID: 19159108
[TBL] [Abstract][Full Text] [Related]
16. Screening of a glutamic acid-binding aptamer from arginine-modified DNA library.
Kuwahara M; Ohsawa K; Kasamatsu T; Shoji A; Sawai H; Ozaki H
Nucleic Acids Symp Ser (Oxf); 2005; (49):81-2. PubMed ID: 17150643
[TBL] [Abstract][Full Text] [Related]
17. Structure-function studies of an engineered scaffold protein derived from Stefin A. II: Development and applications of the SQT variant.
Stadler LK; Hoffmann T; Tomlinson DC; Song Q; Lee T; Busby M; Nyathi Y; Gendra E; Tiede C; Flanagan K; Cockell SJ; Wipat A; Harwood C; Wagner SD; Knowles MA; Davis JJ; Keegan N; Ferrigno PK
Protein Eng Des Sel; 2011 Sep; 24(9):751-63. PubMed ID: 21616931
[TBL] [Abstract][Full Text] [Related]
18. Selection of aptamers for signal transduction proteins by capillary electrophoresis.
Tok J; Lai J; Leung T; Li SF
Electrophoresis; 2010 Jun; 31(12):2055-62. PubMed ID: 20564698
[TBL] [Abstract][Full Text] [Related]
19. Peptide aptamers with binding specificity for the intracellular domain of the ErbB2 receptor interfere with AKT signaling and sensitize breast cancer cells to Taxol.
Kunz C; Borghouts C; Buerger C; Groner B
Mol Cancer Res; 2006 Dec; 4(12):983-98. PubMed ID: 17189388
[TBL] [Abstract][Full Text] [Related]
20. Aptamer selection by high-throughput sequencing and informatic analysis.
Hoon S; Zhou B; Janda KD; Brenner S; Scolnick J
Biotechniques; 2011 Dec; 51(6):413-6. PubMed ID: 22150332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
